Neurocognitive changes and negative symptoms in schizophrenia

被引:9
|
作者
Thoma, P [1 ]
Daum, I [1 ]
机构
[1] Ruhr Univ Bochum, Inst Kognit Neurowissensch, Abt Neuropsychol, D-44801 Bochum, Germany
关键词
D O I
10.1055/s-2004-830233
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
It is widely recognized that schizophrenic disorders are often associated with impairments of cognitive performance. More recently, disorders of higher cognitive control processes ("executive control functions") have captured the attention of researchers as they can considerably impair patients' abilities to live an independent life. Apart from that, considering the heterogeneity of schizophrenia, there have been attempts to relate psychopathological syndromes to changes in distinct cognitive domains. The present review selectively focuses on evidence associating negative symptoms in schizophrenia with deficient performance in specific executive domains. Neurobiological evidence points to biochemical, structural and functional abnormities in the frontal cortex and associated fronto-subcortical circuits as a common basis of both schizophrenic negative symptoms and disorders of executive control. in a multitude of neuropsychological studies, an association between negative symptoms and problems in the domains of response inhibition, multitasking, cognitive flexibility, contextual updating, problem solving and verbal fluency has been reported. in some cases, however, the disorganization syndrome but not the negative syndrome has been linked with impaired behaviour in these domains. The inconsistencies might be partly due to the unsatisfactory differentiation between the two symptom complexes. Future research should furthermore consider a more precise differentiation between primary and secondary negative symptoms. Finally, the assessment of executive control functions should be both specific and ecologically valid.
引用
收藏
页码:333 / 342
页数:14
相关论文
共 50 条
  • [1] ERP correlates of neurocognitive impairment and negative symptoms in schizophrenia
    Mucci, A.
    Giordano, G. M.
    Perrottelli, A.
    Caporusso, E.
    Giuliani, L.
    Pezzella, P.
    INTERNATIONAL JOURNAL OF PSYCHOPHYSIOLOGY, 2023, 188 : 48 - 48
  • [2] BRAIN CHANGES AND NEGATIVE SYMPTOMS IN SCHIZOPHRENIA
    CROW, TJ
    PSYCHOPATHOLOGY, 1995, 28 (01) : 18 - 21
  • [3] Understanding disability in schizophrenia: The role of gender, negative symptoms and neurocognitive deficits
    Jaeger, J
    Berns, S
    Czobor, P
    Ast, MA
    Gomes, C
    Donovan-Lepore, A
    Abdelmessih, S
    SCHIZOPHRENIA RESEARCH, 2001, 49 (1-2) : 110 - 110
  • [4] Neurocognitive performance and negative symptoms: Are they equal in explaining disability in schizophrenia outpatients?
    Villalta-Gil, Victoria
    Vilaplana, Miriam
    Ochoa, Susana
    Haro, Josep Maria
    Dolz, Montserrat
    Usall, Judit
    Cervilla, Jorge
    SCHIZOPHRENIA RESEARCH, 2006, 87 (1-3) : 246 - 253
  • [5] NEUROCOGNITIVE MANAGEMENT OF THE PRIMARY NEGATIVE SYMPTOMS OF SCHIZOPHRENIA: A ROLE OF ATYPICAL ANTIPSYCHOTICS
    Franza, Francesco
    Carpentieri, Gabriella
    De Guglielmo, Serena
    Fasano, Vincenzo
    Fiorentino, Nicoletta
    Perito, Mariangela
    Solomita, Barbara
    Del Buono, Gianfranco
    PSYCHIATRIA DANUBINA, 2016, 28 : S145 - S148
  • [6] NEGATIVE SYMPTOMS AND NEUROCOGNITIVE DEFICITS IN FIRST-EPISODE SCHIZOPHRENIA SPECTRUM DISORDER
    Chang, W. C.
    Hui, L. M.
    Lam, M. L.
    Chan, K. W.
    Wong, H. Y.
    Tang, Y. M.
    Chen, Y. H.
    SCHIZOPHRENIA BULLETIN, 2011, 37 : 240 - 240
  • [7] Symptoms of schizophrenia and neurocognitive test performance
    Shean, G
    Burnett, T
    Eckman, FS
    JOURNAL OF CLINICAL PSYCHOLOGY, 2002, 58 (07) : 723 - 731
  • [8] Lexical Diversity and Other Linguistic Measures in Schizophrenia Associations With Negative Symptoms and Neurocognitive Performance
    Compton, Michael T. T.
    Ku, Benson S. S.
    Covington, Michael A. A.
    Metzger, Celia
    Hogoboom, Anya
    JOURNAL OF NERVOUS AND MENTAL DISEASE, 2023, 211 (08) : 613 - 620
  • [9] Does Integrated Neurocognitive Therapy (INT) reduce severe negative symptoms in schizophrenia outpatients?
    Mueller, Daniel R.
    Khalesi, Zahra
    Benzing, Valentin
    Castiglione, Clelia I.
    Roder, Volker
    SCHIZOPHRENIA RESEARCH, 2017, 188 : 92 - 97
  • [10] Proof-of-concept trial with the neurosterold pregnenolone targeting neurocognitive and negative symptoms in schizophrenia
    Marx, Christine E.
    Keefe, Richard S.
    Leimone, Linda A.
    Hamer, Robert M.
    Bradford, Daniel W.
    Dunn, Lawrence
    Payne, Victoria M.
    Naylor, Jennifer C.
    Savitz, Adam J.
    Strauss, Jennifer L.
    Lieberman, Jeffrey A.
    Shampine, Lawrence J.
    BIOLOGICAL PSYCHIATRY, 2007, 61 (08) : 13S - 13S